The “central vein sign”: is there a place for susceptibility weighted imaging in possible multiple sclerosis?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Susceptibility weighted imaging (SWI) may have the potential to depict the perivenous extent of white matter lesions (WMLs) in multiple sclerosis (MS). We aimed to assess the discriminatory value of the “central vein sign” (CVS).
In a 3-T magnetic resonance imaging (MRI) study, 28 WMLs in 14 patients with at least one circumscribed lesion >5 mm and not more than eight non-confluent lesions >3 mm were prospectively included. Only WMLs in FLAIR images with a maximum diameter of >5 mm were correlated to their SWI equivalent for CVS evaluation.
Five patients fulfilled the revised McDonald criteria for MS and nine patients were given alternative diagnoses. Nineteen MS-WMLs and nine non-MS-WMLs >5 mm were detected. Consensus reading found a central vein in 16 out of 19 MS-WMLs (84 %) and in one out of nine non-MS-WMLs (11 %), respectively. The CVS proved to be a highly significant discriminator (P < 0.001) between MS-WMLs and non-MS-WMLs with a sensitivity, specificity, positive and negative predictive value and accuracy of 84 %, 89 %, 94 %, 73 % and 86 %, respectively. Inter-rater agreement was good (κ = 0.77).
Even though the CVS is not exclusively found in MS-WMLs, SWI may be a useful adjunct in patients with possible MS.
• MRI continues to yield further information concerning MS lesions.
• SWI adds diagnostic information in patients with possible MS.
• The “central vein sign” was predominantly seen in MS lesions.
• The “central vein sign” helps discriminate between MS and non-MS lesions.
- Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938–952 CrossRef
- Renoux C, Vukusic S, Mikaeloff Y et al (2007) Natural history of multiple sclerosis with childhood onset. N Engl J Med 356:2603–2613 CrossRef
- Okuda DT, Mowry EM, Beheshtian A et al (2009) Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology 72:800–805 CrossRef
- Poser CM, Paty DW, Scheinberg L et al (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1:227–231 CrossRef
- McDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127 CrossRef
- Tintoré M, Rovira A, Río J et al (2003) New diagnostic criteria for multiple sclerosis. Application in first demyelinating episode. Neurology 60:27–30 CrossRef
- Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302 CrossRef
- Filippi M, Rocca MA (2011) MR imaging of multiple sclerosis. Radiology 259:659–681 CrossRef
- Fazekas F, Kleinert R, Offenbacher H et al (1991) The morphologic correlate of incidental punctate white matter hyperintensities on MR images. AJNR Am J Neuroradiol 12:915–921
- Breteler MM, van Swieten JC, Bots ML et al (1994) Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 44:1246–1252 CrossRef
- de Leeuw FE, de Groot JC, Achten E et al (2001) Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 70:9–14 CrossRef
- Putnam TJ (1933) The pathogenesis of multiple sclerosis: a possible vascular factor. N Engl J Med 209:786–790 CrossRef
- Fog T (1965) The topography of plaques in multiple sclerosis with special reference to cerebral plaques. Acta Neurol Scand Suppl 15:1–161
- Horowitz AL, Kaplan RD, Grewe G, White RT, Salberg LM (1989) The ovoid lesion: a new MR observation in patients with multiple sclerosis. AJNR Am J Neuroradiol 10:303–305
- Filippi M, Rocca MA, Barkhof F et al (2012) Attendees of the Correlation between Pathological MRI findings in MS workshop. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol 11:349–360 CrossRef
- Ge Y, Zohrabian VM, Grossman RI (2008) Seven-Tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis. Arch Neurol 65:812–816 CrossRef
- Tallantyre EC, Morgan PS, Dixon JE et al (2009) A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions. Invest Radiol 44:491–494 CrossRef
- Grabner G, Dal-Bianco A, Schernthaner M, Vass K, Lassmann H, Trattnig S (2011) Analysis of multiple sclerosis lesions using a fusion of 3.0 T FLAIR and 7.0 T SWI phase: FLAIR SWI. J Magn Reson Imaging 33:543–549 CrossRef
- Haacke EM, Xu Y, Cheng YC, Reichenbach JR (2004) Susceptibility weighted imaging (SWI). Magn Reson Med 52:612–618 CrossRef
- Lummel N, Boeckh-Behrens T, Schoepf V, Burke M, Brückmann H, Linn J (2011) Presence of a central vein within white matter lesions on susceptibility weighted imaging: a specific finding for multiple sclerosis? Neuroradiology 53:311–317 CrossRef
- Carmody DP, Dunn SM, Boddie-Willis AS, DeMarco JK, Lewis M (2004) A quantitative measure of myelination development in infants, using MR images. Neuroradiology 46:781–786 CrossRef
- Dinov ID (2006) SOCR: Statistics Online Computational Resource. J Stat Softw 16:1–16
- Jacobs DL, Beck RW, Simon JH et al (2000) Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 343:898–904 CrossRef
- Enzinger C, Smith S, Fazekas F et al (2006) Lesion probability maps of white matter hyperintensities in elderly individuals: results of the Austrian stroke prevention study. J Neurol 253:1064–1070 CrossRef
- Barkhof F, Filippi M, Miller DH et al (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120:2059–2069 CrossRef
- Tan IL, van Schijndel RA, Pouwels PJ, van Walderveen MA, Reichenbach JR, Manoliu RA, Barkhof F (2000) MR venography of multiple sclerosis. AJNR Am J Neuroradiol 21:1039–1042
- Adams CWM, Poston RN, Buk SJ (1989) Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J Neurol Sci 92:291–306 CrossRef
- Ge Y, Zohrabian VM, Osa EO et al (2009) Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility-weighted imaging at 3.0 Tesla. J Magn Reson Imaging 29:1190–1194 CrossRef
- Zivadinov R, Poloni GU, Marr K et al (2011) Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency. BMC Neurol 11:128 CrossRef
- Reichenbach JR, Venkatesan R, Schillinger DJ, Kido DK, Haacke EM (1997) Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 204:272–277
- Hodel J, Rodallec M, Gerber S et al (2012) Susceptibility weighted magnetic resonance sequences “SWAN, SWI and VenoBOLD”: technical aspects and clinical applications. J Neuroradiol 39:71–86
- The “central vein sign”: is there a place for susceptibility weighted imaging in possible multiple sclerosis?
Volume 23, Issue 7 , pp 1956-1962
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Multiple sclerosis
- White matter lesions
- Central vein sign
- Magnetic resonance imaging
- Susceptibility weighted imaging
- Industry Sectors
- Author Affiliations
- 1. Klinikum Klagenfurt, Institute of Diagnostic and Interventional Radiology, Feschnigstrasse 11, 9020, Klagenfurt, Austria
- 2. Department of Radiology, Medical University Graz, Auenbruggerplatz 9, 8010, Graz, Austria
- 3. Department of Neurology, Klinikum Klagenfurt, Feschnigstrasse 11, 9020, Klagenfurt, Austria